Tweet
World J Radiol
. 2024 Sep 28;16(9):446-452.
doi: 10.4329/wjr.v16.i9.446. Myelin oligodendrocyte glycoprotein-associated transverse myelitis after SARS-CoV-2 infection: A case report
Jian-Rong Zheng 1 2 , Jun-Lei Chang 3 , Jun Hu 1 , Zhi-Jian Lin 1 , Kai-Hua Lin 1 , Bi-Hua Lu 4 , Xu-Hui Chen 5 , Zhi-Gang Liu 6
Affiliations
Background: Cases of myelin oligodendrocyte glycoprotein (MOG) antibody-related disease have a history of coronavirus disease 2019 infection or its vaccination before disease onset. Severe acute respiratory syndrome virus 2 (SARS-CoV-2) infection has been considered to be a trigger of central nervous system autoimmune diseases.
Case summary: Here we report a 20-year male with MOG-associated transverse myelitis after a SARS-CoV-2 infection. The patient received a near-complete recovery after standard immunological treatments.
Conclusion: Attention should be paid to the evaluation of typical or atypical neurological symptoms that may be triggered by SARS-CoV-2 infection.
Keywords: COVID-19; Case report; Myelin oligodendrocyte glycoprotein antibody-associated disease; Myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis; SARS-CoV-2.
. 2024 Sep 28;16(9):446-452.
doi: 10.4329/wjr.v16.i9.446. Myelin oligodendrocyte glycoprotein-associated transverse myelitis after SARS-CoV-2 infection: A case report
Jian-Rong Zheng 1 2 , Jun-Lei Chang 3 , Jun Hu 1 , Zhi-Jian Lin 1 , Kai-Hua Lin 1 , Bi-Hua Lu 4 , Xu-Hui Chen 5 , Zhi-Gang Liu 6
Affiliations
- PMID: 39355395
- PMCID: PMC11440270
- DOI: 10.4329/wjr.v16.i9.446
Background: Cases of myelin oligodendrocyte glycoprotein (MOG) antibody-related disease have a history of coronavirus disease 2019 infection or its vaccination before disease onset. Severe acute respiratory syndrome virus 2 (SARS-CoV-2) infection has been considered to be a trigger of central nervous system autoimmune diseases.
Case summary: Here we report a 20-year male with MOG-associated transverse myelitis after a SARS-CoV-2 infection. The patient received a near-complete recovery after standard immunological treatments.
Conclusion: Attention should be paid to the evaluation of typical or atypical neurological symptoms that may be triggered by SARS-CoV-2 infection.
Keywords: COVID-19; Case report; Myelin oligodendrocyte glycoprotein antibody-associated disease; Myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis; SARS-CoV-2.